AveXis is a biotechnology company focused on the development of gene therapies for the treatment of rare and life-threatening genetic diseases. The company leverages cutting-edge technology to create potentially curative gene replacement therapies for patients with serious genetic disorders.

Our Vision: To understand and use the therapeutic potential of the cannabis plant and thereby improve the quality of life for patients.Our Mission: To make cannabis-based medicines available to a wide patient population through the development of innovative, rigorously tested and regulator-approved products.

COM:AVEXTRA

AveXis

Analysis Not Available